Nova Systems will play a key role in supporting EPE in the ongoing maintenance and support of two Weapons Technical Intelligence (WTI) labs, as part of the Land 154 Phase 2 sustainment program.
It was announced last month that EPE had been awarded the Land 154 Phase 2 contract, a capability program that will aim to improve the Australian Defence Force’s joint counter-improvised explosive device response.
The Weapons Technical Intelligence (WTI) facilities are a series of deployable containers, consisting predominantly of specialist scientific laboratory equipment.
Being deployable means they can be transported and utilised on-scene, allowing for rapid assessment of weapons effects and explosive devices.
Similar facilities developed overseas have enabled the rapid deployment of counter-measures during operations to protect Australian Defence Force (ADF) and allied forces, Nova Systems said in a release announcing the partnership.
“Nova Systems is a true Australian success story. The partnership between EPE and Nova Systems creates an all-Australian team to optimise this capability, while further building specialist scientific, engineering and weapons technical intelligence expertise here in Australia,” EPE’s Land 154-2 Project Director, Keith Mollison, said.
“This capability gives Australia a seat on the world stage, aligning with AUKUS and NATO partners to have a deployable WTI capability that improves interoperability and will save lives," Nova Systems Chief Operating Officer, Steven Robinson, added.
“As part of our partnership with EPE, Nova Systems will ensure the WTI labs are sustained and ready for deployment at a moment’s notice.
“EPE’s expertise in level 2 exploitation and specialist project management is complemented by Nova Systems’ world-leading engineering capability.
“Both companies are Australian-owned and veteran founded, together building enduring sovereign skills and capability, which makes for the perfect partnership to support the ADF.”
Nova Systems says the five-year contract includes a long-term sustainment opportunity, with the labs based in Brisbane, Queensland and Edinburgh, South Australia.